Informa PLC
03 November 2006
3 November 2006
Informa plc
Statement regarding approach
Further to the announcement dated 19 October, Informa plc ('Informa' or the
'Company') announces that, following discussions with Springer Science +
Business Media ('SSBM'), whose principal shareholders are Cinven and Candover,
it has today received a final proposal from SSBM regarding a possible offer for
the entire issued and to be issued share capital of the Company at 630p per
share in cash. This proposal was subject, inter alia, to various pre-conditions
including financing and due diligence.
The Board believes that this offer significantly undervalues Informa and its
future prospects. Informa is currently trading comfortably in line with the
Board's expectations for 2006 and the Board is confident of another strong set
of results in 2007. Consequently, the Board believes Informa will deliver
shareholder value in excess of this possible offer and has therefore rejected
the proposal and has terminated discussions with SSBM.
Enquiries:
The Maitland Consultancy
Angus Maitland - 020 7379 5151
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.